tirzepatide nash for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial Effects of Tirzepatide on Patients

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

Get Celsius Sparkling Arctic Vibe delivered to you in as fast as 1 hour with ALDI same-day delivery or curbside pickup.

GLP-1 meds can support weight loss, but for women over 50, muscle, strength, protein, and mindset matter just as much

Explore Zappy Health's telehealth services offering FDA-approved Wegovy (semaglutide) for weight loss

Discover the safety considerations, potential interactions, and what to discuss with your GP when using these medications concurrently for weight management and mental health.

She noticed a 15-pound weight loss and debilitating fatigue within that timeframe